Published on in Vol 13 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64114, first published .
Real-Time, Risk-Based Clinical Trial Quality Management in China: Development of a Digital Monitoring Platform

Real-Time, Risk-Based Clinical Trial Quality Management in China: Development of a Digital Monitoring Platform

Real-Time, Risk-Based Clinical Trial Quality Management in China: Development of a Digital Monitoring Platform

Min Jiang   1 * , MSc ;   Shuhua Zhao   2 * , MSc ;   Yun Mei   3 , MSc ;   Zhiying Fu   2 , MSc ;   Yannan Yuan   2 , MSc ;   Jie Ai   3 , MSc ;   Yuan Sheng   4 , PhD ;   Ying Gong   4 , BSc ;   Jingjing Chen   4 , MSc

1 State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, National Drug Clinical Trial Center, Peking University Cancer Hospital & Institute, Beijing, China

2 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), National Drug Clinical Trial Center, Peking University Cancer Hospital & Institute, Beijing, China

3 Yidu Cloud (Beijing) Technology Co, Ltd, Beijing, China

4 Pfizer (China) Research and Development Co, Ltd, Shanghai, China

*these authors contributed equally

Corresponding Author:

  • Min Jiang, MSc
  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers
  • Beijing Key Laboratory of Carcinogenesis and Translational Research, National Drug Clinical Trial Center, Peking University Cancer Hospital & Institute
  • 52 Fucheng Rd, Haidian District
  • Beijing
  • China
  • Phone: 86 01088196664
  • Email: gcp_jiangm@bjcancer.org.cn